Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E86.
   PubMed Web of Science ®Google Scholar
• Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomark Prev. 2009;18(6):1688–1694.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Harlan LC, Lund JL, et al. Patterns of colorectal cancer care in the United States: 1990–2010. J Natl Cancer Inst. 2015;107(10):djv198.
   PubMedGoogle Scholar
• Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696.
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Jakab M, Gerdtham U, et al. Comparative financing analysis and political economy of noncommunicable diseases. J Med Econ. 2019;22(8):722–727.
   PubMed Web of Science ®Google Scholar
• Vekic B, Dragojevic-Simic V, Jakovljevic MM, et al. Medical cost of colorectal cancer services in Serbia Between 2014 and 2017: national data report. Front Pharmacol. 2019;10:526.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4(11):1553–1568.
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Malmose-Stapelfeldt C, Milovanovic O, et al. Disability, Work absenteeism, sickness Benefits, and cancer in selected european OecD countries—forecasts to 2020. Front Public Health. 2017;5:23.
   PubMed Web of Science ®Google Scholar
• Jakovljevic M, Fernandes PO, Teixeira JP, et al. Underlying differences in health spending within the World Health Organisation Europe Region—comparing EU15, EU post-2004, CIS, EU candidate, and CARINFONET countries. IJERPH. 2019;16(17):3043.
   Web of Science ®Google Scholar
• Dagovic A, Walstra KM, Gutzwiller FS, et al. Resource use and costs of newly diagnosed cancer initial medical care. Eur J Oncol. 2014;19(3):166–184.
   Google Scholar
• Qaseem A, Denberg TD, Hopkins RH, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156(5):378–386.
   PubMed Web of Science ®Google Scholar
• von Karsa L, Patnick J, Segnan N, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51–59.
   PubMed Web of Science ®Google Scholar
• Zhang J, Cheng Z, Ma Y, et al. Effectiveness of screening modalities in colorectal cancer: a network meta-analysis. Clin Colorect Cancer. 2017;16(4):252–263.
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(23):2564–2575.
   PubMed Web of Science ®Google Scholar
• Sharp L, Tilson L, Whyte S, et al. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. Br J Cancer. 2012;106(5):805–816.
   PubMed Web of Science ®Google Scholar
• Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570–1595.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, van Rossum LG, van Turenhout ST, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer. 2011;128(1):3–11.
   PubMed Web of Science ®Google Scholar
• Brenner H, Tao S. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer. 2013;49(14):3049–3054.
   PubMed Web of Science ®Google Scholar
• Sano Y, Byeon JS, Li XB, et al. Colorectal cancer screening of the general population in East Asia. Dig Endosc. 2016;28(3):243–249.
   PubMed Web of Science ®Google Scholar
• Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104(3):739.
   PubMed Web of Science ®Google Scholar
• Burt RW, Cannon JA, David DS, et al. Colorectal cancer screening. J Natl Compr Canc Netw. 2013;11(12):1538–1575.
   PubMed Web of Science ®Google Scholar
• Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33(1):88–100.
   PubMed Web of Science ®Google Scholar
• Leite NC, Salles GF, Araujo AL, et al. Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus. Liver Int. 2009;29(1):113–119.
   PubMed Web of Science ®Google Scholar
• Thai Health Technology Assessment Guideline Working Group. Thai health technology assessment guideline: Bangkok: Chulalongkorn University Press; 2008.
   Google Scholar
• Teerawattananon Y, Tritasavit N, Suchonwanich N, et al. The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand. Z Evid Fortbild Qual Gesundhwes. 2014;108(7):397–404.
   PubMedGoogle Scholar
• Permsuwan U, Kansinee G, Buddhawongsa P. Handling time in economic evaluation studies. J Med Assoc Thailand. 2014;97(5):S50–S58.
   PubMedGoogle Scholar
• National Cancer Institute Thailand. Guideline on screening, diagnosis and treatment of colorectal cancer. Bangkok: National Cancer Institute Thailand; 2015.
   Google Scholar
• Aswakul P, Prachayakul V, Lohsiriwat V, et al. Screening colonoscopy from a large single center of Thailand-something needs to be changed?. Asian Pac J Cancer Prev. 2012;13(4):1361–1364.
   PubMedGoogle Scholar
• Siripongpreeda B, Mahidol C, Dusitanond N, et al. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases. BMC Gastroenterol. 2016;16(1):101.
   PubMedGoogle Scholar
• Khuhaprema T, Sangrajrang S, Lalitwongsa S, et al. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ open. 2014;4(1):e003671.
   PubMed Web of Science ®Google Scholar
• Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171–81.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Hassan C, Halligan S, et al. Colorectal cancer: CT colonography and colonoscopy for detection—systematic review and meta-analysis. Radiology. 2011;259(2):393–405.
   PubMed Web of Science ®Google Scholar
• Allameh Z, Davari M, Emami M. Sensitivity and specificity of colorectal cancer mass screening methods: a systematic review of the literature. Iran J Cancer Prev. 2011;4(2):88–105.
   Google Scholar
• Saengow U, Chongsuwiwatvong V, Geater A, et al. Preferences and acceptance of colorectal cancer screening in Thailand. Asian Pac J Cancer Prev. 2015;16(6):2269–2276.
   PubMedGoogle Scholar
• Gopalappa C, Aydogan-Cremaschi S, Das TK, et al. Probability model for estimating colorectal polyp progression rates. Health care Manag Sci. 2011;14(1):1–21.
   PubMed Web of Science ®Google Scholar
• Leshno M, Halpern Z, Arber N. Cost-effectiveness of colorectal cancer screening in the average risk population. Health Care Manage Sci. 2003;6(3):165–174.
   PubMedGoogle Scholar
• World Health Organization. Life tables by country: Thailand; 2016. [cited 2018 Oct 18]. http://apps.who.int/gho/data/view.main.61640?lang=en.
   Google Scholar
• Techawathanawanna S, Nimmannit A, Akewanlop C. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital. J Med Assoc Thai. 2012;95(2):S189–S98.
   PubMedGoogle Scholar
• Laohavinij S, Maneechavakajorn J, Techatanol P. Prognostic factors for survival in colorectal cancer patients. J Med Assoc Thai. 2010;93(10):1156–1166.
   PubMedGoogle Scholar
• Sermsri N, Boonpipattanapong T, Prechawittayakul P, et al. Influence of payer source on treatment and outcomes in colorectal cancer patients in a university hospital in Thailand. Asian Pac J Cancer Prev. 2014;15(20):9015–9019.
   PubMedGoogle Scholar
• Riewpaiboon A. Standard cost lists for health technology assessment. Nonthaburi: Health Intervention and Technology Assessment Program (HITAP); 2011.
   Google Scholar
• Reumkens A, Rondagh EJ, Bakker CM, et al. Post-colonoscopy complications: a systematic review, time trends, and meta-analysis of population-based studies. Am J Gastroenterol. 2016;111(8):1092–1101.
   PubMed Web of Science ®Google Scholar
• Tongsiri S, Cairns J. Estimating population-based values for EQ-5D health states in Thailand. Value Health. 2011;14(8):1142–1145.
   PubMed Web of Science ®Google Scholar
• Kimman M, Vathesatogkit P, Woodward M, et al. Validity of the Thai EQ-5D in an occupational population in Thailand. Qual Life Res. 2013;22(6):1499–1506.
   PubMed Web of Science ®Google Scholar
• Ness RM, Holmes AM, Klein R, et al. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol. 1999;94(6):1650–1657.
   PubMed Web of Science ®Google Scholar
• Riewpaiboon A. Measurement of costs. J Med Assoc Thailand Chotmaihet thangphaet. 2008;91:S28–S37.
   PubMedGoogle Scholar
• Bank of Thailand. Foreign Exchange Rates; 2017. [cited 2018 Oct 18]. http://www2.bot.or.th/statistics/ReportPage.aspx?reportID=123&language=eng
   Google Scholar
• Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation: Oup Oxford; 2006.
   Google Scholar
• Population of Thailand Classified by Age; 2018. [cited 2019 May 15]. http://stat.dopa.go.th/stat/statnew/upstat_age_disp.php
   Google Scholar
• Richter JM, Campbell EJ, Chung DC. Interval colorectal cancer after colonoscopy. Clin Colorectal Cancer. 2015;14(1):46–51.
   PubMed Web of Science ®Google Scholar
• Le Clercq CMC, Bouwens MWE, Rondagh EJA, et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut. 2014;63(6):957–963.
   PubMed Web of Science ®Google Scholar
• Erichsen R, Baron JA, Stoffel EM, et al. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol. 2013;108(8):1332–1340.
   PubMed Web of Science ®Google Scholar
• Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening – an overview. Best Pract Res Clin Gastroenterol. 2010;24(4):439–449.
   PubMed Web of Science ®Google Scholar
• Patel SS, Kilgore ML. Cost effectiveness of colorectal cancer screening strategies. Cancer Control. 2015;22(2):248–258.
   PubMed Web of Science ®Google Scholar
• Levin TR, Corley DA, Jensen CD, et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155(5):1383–1391.e5.
   PubMed Web of Science ®Google Scholar
• Vicentini M, Zorzi M, Bovo E, et al. Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: results from the IMPATTO study. Int J Cancer. 2019;145(1):110–121.
   PubMed Web of Science ®Google Scholar
• Zauber A, Knudsen A, Rutter C, et al. Evaluating the benefits and harms of colorectal cancer screening strategies: a collaborative modeling approach AHRQ Publication 14-05203-EF-2 2015. Rockville, MD: Agency for Healthcare Research and Quality; 2015.
   Google Scholar
• Wolf AM, Fontham ET, Church TR, et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. Cancer J Clin. 2018;68(4):250–281.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Ginsburg O, Fojo T. Cancer economics, policy and politics: what informs the debate? Perspectives from the EU, Canada and US. J Cancer Policy. 2014;2(1):1–11.
   Google Scholar
• Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: Recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016–1030.
   PubMed Web of Science ®Google Scholar
• Pox CP. Controversies in colorectal cancer screening. Digestion. 2014;89(4):274–281.
   PubMed Web of Science ®Google Scholar
• Drummond M, Barbieri M, Cook J, et al. Transferability of economic evaluations across jurisdictions. International Society for Pharmacoeconomic and Outcomes Research (ISPOR)—13th International Meeting, Toronto; 2008.
   Google Scholar